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ABSTRACT
Objective: Validation of water treatment systems is required to achieve water with all preferred quality attributes. This also delivers a circumstantial 
to establish a total control over the process which screens efficacy, safety, and ultimately, the process outcomes. The goal of steering validation is to 
establish that a process when operated within established limits, yields a product of reliable and definite quality with a high degree of assurance.
Methods: The current work is an effort to deliberate several aspects of validation comprising different approaches, machineries of water purification 
systems, equipment qualifications, performance testing phases, microbial and chemical analysis of water samples, documentation, and post-validation 
monitoring. Mainly the validation is done for new water plants in pharmaceutical industry.
Results and Discussion: Sampling of water was carried out after each step in the purification process, and the results were found within limits.
Conclusion: Water purification systems must be operated in the interior regulatory guidelines as with pharmaceutical manufacture facilities. 
Successful achievement of validation is confirmed by various testing phases. Usually, a three-phase testing approach is recommended over an extended 
period to prove reliability and robustness of the system for producing water of specified quality with a high degree of assurance.
Keywords: Validation, Water purification systems, Quality attributes, Pharmaceutical manufacture facilities, Microbial and chemical analysis.
INTRODUCTION
•	 High-quality	 water	 is	 needed	 for	 the	 manufacturing	 of	
pharmaceuticals. Water is the most regularly used raw material in 
pharmaceutical manufacturing.
•	 Water	 is	 directly	 or	 indirectly	 used	 in	 the	 pharmaceutical	
manufacturing such as a major part in injectable products and in 
cleaning of manufacturing equipment.
•	 It	 is	 one	of	 the	 raw	materials	 that	 are	 regularly	 treated	by	 the	
pharmaceutical manufacturer previous to use because it cannot 
be provided by the vendor. Water is, therefore, an important raw 
material in good manufacturing practices (GMP) and in validating 
the manufacturing process.
Why purification?
Although tap water is sensibly pure, it is always variable due to seasonal 
or regional variation in quality.
•	 To	remove	impurities	and	avoid	microbial	contamination	of	products.
•	 Pretreatment	is	contingent	on	quality	of	feed	water.
Water is referred as “the elixir of life” - this term is most suitable to the 
pharmaceutical industry for which the quality of water is precarious and 
a	high	importance.	It	is	an	essential	component	of	various	pharmaceutical	
preparations and is also used to clean process equipment and in future, 
plays an essential role in pharmaceutical processing’s [1].
It	is,	thus,	significant	that	water	should	meet	set	values	given	in	different	
official texts; moreover, the water purification system frequently 
delivers the definite quantity and quality of water so as to confirm 
that there is no contamination of the equipment or product. Several 
grades of this raw material (i.e., water) are described by United States 
Pharmacopoeia (USP), based on several quality parameters such as 
microbiological values, presence of contaminants including endotoxins, 
conductivity, nitrates, heavy metals, and total organic carbon (TOC). 
Water must be constantly tested and must comply with well-defined 
quality attributes [2].
From the last few years, in the pharmaceutical industry, there has 
been	a	rigorous	focus	on	validation	methodologies.	Its	real	importance	
within a productive course is recognized in relative to a product’s 
quality attributes such as safety, purity, and effectiveness. Guidelines 
pertaining to the general principles of process validation and has 
also defined process validation is published by the Food and Drug 
Administration (FDA) “as an established documented evidence which 
delivers a high degree of assurance that a specific process will reliably 
produce a product meeting its predetermined specifications and quality 
characteristics” [3].
The term, validation, is used to cover the entire field of current 
GMP, and thus, it is also a section of the quality assurance program. 
Validation is legible through the established documentation and it 
assurances a manufacturing process with assured product quality and 
similarity.
To obtain water with all the desired quality characteristics, validation 
of water purification systems is mandatory [4]. Production, storage 
of pharmaceutical water, and conveyance system must be validated 
because end-product testing alone is insufficient indication to 
confirm with a high degree of assurance that the system operates as 
it is purported, water treatment systems, which are highly dynamic in 
nature, must be validated, monitored closely and controlled to cater 
for the ever escalating quality needs of the pharmaceutical industry. 
This article is intended to discuss the consistency effectiveness and 
reproducibility of a water purification system along with its validation 
aspects.
METHODS [5-7]
A. Raw water: Well water supplied by municipalities with preliminary 
treatments	like	filtration	and	chlorination.
B.	Water	 softening:	 In	 this	mechanism,	 the	 calcium	and	magnesium	
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1. Regeneration frequency.
2. Requirement to sanitize the bed.
3. Replacement of resin.
4. Monitoring pressure drop and hardness.
C. Activated carbon: Used to remove chlorine and other organic materials 
from the water. The consideration includes:
1. Backwash frequency.
2. Continuous recirculation.
3. Requirements to sanitize beds.















E.	 Ion	 exchange: It	 is	 used	 to	 remove	 dissolved	 ionic	 impurities.	
Consideration includes:
1. Measuring quality and condition at various stages through the 
DI	train,	e.g.,	influent,	post	caution,	post-anion,	post	mixed,	etc,
2. Varying conditions during the service cycles,
3. Microbial conditions of bed,
4. Possible continuous recycling of water through the resin bed,
5.	 Quality	of	regenerated	chemical-	H2SO4,	HCL,	NaOH,
6.	 Condition	and	quality	of	air	used	for	air	blow	on	mixed	bed	units,
7. Dissolved and colloidal silica not detected by conductivity,
8. Amines from resins new and old,
9.	 Sanitization	and	regeneration,
10. Frequency of regeneration and bed size,
11.	 pH	adjustment	to	meet	USP	requirements,
12.	 pH	measurement	problems	[8].
F. Reverse osmosis (RO): RO treatment will remove a large portion of salt 










The consideration is similar to RO.
H.	Distillation:
1. Single effect thermal distillation,
2. Multiple effect thermal distillation,
3. Vapor compression distillation.
I.	Ultraviolet	radiation:	Validity	of	this	method	for	pharmaceutical	water	
usage is not validated.
J.	Heat:	The	heating	and	storing	of	water	at	80°C	has	been	shown	effective	
to control the microbial quality.
Equipment validation
Design considerations
Design considerations comprise general information regarding 
several components or parts of water purification systems. The 
systems should be constructed using modular, off-the-shelf 
purification components to control cost and maximize validation 
efficiency, which finally fulfills pharmacopeia requirements [7]. 
These considerations must be designed correctly to prevent 
microbial growth. Materials of construction must be designated 





Fabrication of SS304 pipeline shall be done by argon welding and 
fabrication	of	CPVC	pipeline	shall	be	done	solvent	or	threaded	fittings.
Fig. 1: Microbial analysis report of portable water
Fig. 2: Microbial analysis report of purified water
Fig. 3: Microbial analysis report of purified water
Fig. 4: Microbial analysis report of purified water
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as per 3D rule in the fabricated post-treatment system.
•	 The	pre	and	post-treatment	system	and	piping	shall	be	compatible	
for heat sanitation and chemical cleaning.
System design and overview
Functional description
The PW generation system consists of raw water tank (client scope), 
sodium hypochlorite dosing system, raw water pump, sand filter, 
softener soft water storage tank, UF feed pump, UF fast flush pump, 
10	 µ	 micron	 cartridge	 filter,	 UF	 membrane,	 UF	 and	 RO	 CIP	 system,	
antiscalent dosing system, sodium meta Bi-sulphite dosing system, ORP 
transmitter	with	dump	valve,	RO-I	feed	tank,	RO-I	water	storage	tank,	
RO-I	 feed	water	 storage	 tank,	RO-I	 feed	pumps,	5	µ	micron	cartridge	
filter,	 RO-I	 high	 pressure	 pump,	 RO	 system	 I,	 pH	 correction	 dosing	
system,	RO-II	 feed	 tank,	RO-II	 feed	pump,	1	µ	micron	 cartridge	 filter,	
RO	II	high	pressure	pump,	RO	system	II,	electrodeionization	unit	and	
ultraviolet	disinfectant,	isolation	valves	and	instruments	[9].
The purified water is generated by dosing sodium hypochlorite, 
filtering through sand filter softening through softener to reduce 
the	 hardness,	 reducing	 microbial	 load	 and	 SDI	 below	 <1	 through	
ultrafiltration unit, neutralizing the chlorine through sodium meta 
Bi-sulphate dosing, then dosing antiscalant for prevent scaling to 
RO	membrane,	 then	storing	 in	RO-I	 feed	 tank,	 then	 feeding	water	 to	
RO-I	 system	 for	 removal	of	 total	dissolved	solids	 through	10	micron	
cartridge	 filter,	 then	RO-I	permeate	water	 in	RO-I	 storage	 tank,	 then	
this	 RO-I	 permeate	water	 stored	 in	 an	 RO-I	water	 storage	 tank	 and	
it	 is	 transferred	 through	 the	 RO-I	 water	 transfer	 pump	 to	 the	 RO-I	





is done by electro deionization system and finally disinfecting bacteria 
by	ultraviolet	disinfectant	system.	Then	it	stored	in	2.5KL	PW	storage	
tank [10]. Treated water quality standards are shown in Table1.
The PW generation system designed for continuous generation of 
purified water, if there is no requirement of water RO system and 
electrodeionization unit, will be in standby mode and auto flushing will 
be programmed for every specific time. System sanitization has to be 
done during restarting and fouling of the system [11]. Design flow rates 
are shown in figure 2.
This generation system is controlled by centralized control panel; 
critical parameters, viz.,	Tank	levels,	ORP,	pH,	flow	conductivity’s	shall	
be continuously monitored and controlled.
Installation qualification (IQ)
IQ	 ensures	 and	 proves	 that	 the	 system	 has	 been	 supplied	 and	
installed correctly and meets the predetermined specifications of the 
users.	It	usually	involves	the	generation	of	an	IQ	protocol,	a	test	and	
inspection plan for the system. All installation parameters should 




steam and feed water. Each must be checked properly at the time of 
installation of equipment for water treatment systems.
•	 Calibration	of	 all	method	 controlling	 instruments	 according	 to	
written	procedures	and	certification	that	they	meet	the	indicated	





The purpose of OQ is to launch, through documented testing, that all 
critical components are accomplished of operating within established 
limits and tolerances.
•	 It	 is	 the	 functional	 testing	 of	 system	 components	 are	 critical	
components.
•	 The	purpose	of	OQ	is	to	confirm	and	document	that	the	water	supply	
system provides acceptable operational control under “at-rest” 
conditions [12-14].
OQ checks
•	 Capability	 to	provide	water	of	 adequate	quantity	 and	quality	 to	
ensure	accomplishment	of	specifications.
•	 Capability	 to	 preserve	 general	 parameters	 such	 as	 pressure,	
temperature,	flow	at	set	points.
•	 Capability	 to	maintain	 any	 critical	 parameters	 (Microbial	 level,	
Table 1: Treated water quality standards
Parameters Limit
pH 5.5-7.0
Conductivity (purified water) <1.25	µS/cm	@	25°C
TOC <500	ppb
TVC <100	cfu/ml
TOC: Total organic carbon
Table 2: Design flow rates
Particulars Flow (m3/hr)
Multi grade filter 12
Softener 12










Softener Pre UF RO‑I permeate RO‑II permeate EDI permeate
Turbidity <10	NTU <10	NTU <10	NTU Nil Nil Nil




Same as in feed water <100	µs/cm <30	µs/cm ≤1.25	µs/cm	@	25°C
TOC Same as in 
feed water
Same as in feed water <2	ppm <2	ppm <500	ppb <500	ppb
Ph Same as in 
feed water
7-8 Same as in feed water 5-7 5-7 5-7
TMC Same as in 
feed water
Same as in feed water <100	cfu/ml <100	cfu/ml <100	cfu/ml <100	cfu/ml
TOC:	Total	organic	carbon,	EDI:	Electrodeionization,	TMC:	Total	microbial	count
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provides acceptable control under “full operational” conditions.
•	 PQ	must	follow	successful	completion	of	IQ	and	OQ.
•	 PQ	verifies	that	completed	time,	critical	parameters,	as	defined	in	
the DQ are being achieved.
According to the FDA’s advice
“The observed variability of the equipment between and within runs 
used as a basis for defining the total number of trials selected for the 
subsequent PQ studies of the process.”





Three	 phase	 methodology	 suggested	 according	 to	 WHO	 Technical	
Report	Series	929	to	prove	reliability	and	robustness.











•	 Proper	 operating	 ranges	 and	 finalize	 operating,	 cleaning,	




operation, maintenance, troubleshooting, and sanitization.
•	 Measure	provisional	alert	and	action	levels.
•	 Develop	and	define	test-failure	process.







•	 Dependable	 operation	 within	 recognized	 ranges.	 Hence,	 it	
demonstrates that the system is in control.
•	 Consistent	production	and	delivery	of	water	of	the	required	amount	
and quality when the system is operated according with the SOPs.
Phase 3 (verifying long-term control)
•	 Over	1	year	after	the	acceptable completion of phase 2.
•	 Water	can	be	utilized	for	manufacturing	purposes	during	this	phase.
•	 Demonstrate:	 Extended	 consistent	 performance,	 that	 seasonal	
variations are evaluated, sample locations, sampling frequencies 
and tests should be reduced to the normal routine pattern based on 
well-known procedures proven during phases 1 and 2.
Monitoring






•	 For	example,	 stable state can be achieved by applying automatic 
continuous checking of TOC and conductivity of the water system. 
They are the major quality attributes of water by which organic and 
inorganic impurities can be determined.
Maintenance
A controlled, documented maintenance covers:
•	 Definite	frequency	with	plan	and	instructions,
•	 Calibration	 program,	 SOPs	 for	 tasks,	 record	 and	 review	 of	
complications and faults during maintenance,
•	 System	sanitization	and	bioburden	 control,	 systems	 in	place	 to	




Revalidation and change control
•	 A	laboratory	applying	a	definite	method	should	confirm	that	they	





















Table 5: Sampling point: SP02 (After NaOCl dosing)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 6.5-8.5 6.88 6.89 6.98 7.01 7.04 6.99 6.87 6.88 6.91 6.97
Total hardness (as 
calcium carbonate)
NMT	600	mg/l 52 57 53 47 56 58 55 61 58 59
Chloride (as 
chlorine)
NMT	1000	mg/l 547 587 548 598 614 574 542 564 542 528
Dissolved solids NMT	2000	mg/l 624 604 574 582 564 555 594 542 554 528
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have documentary evidence that the method has been appropriately 
validated. “The accountability is with the user to ensure that the 
validation	documented	 in	 the	method	 is	 sufficiently	 complete	 to	





impact on whole system.
•	 Revalidation	and	assessment	should	be	performed	depending	upon	
the impact of the change on system.
RESULTS AND DISCUSSIONS




matter from the water. So by this process, foreign particles are removed 
Table 6: Sampling point: SP04 (after multi grade filter)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 6.5-8.5 7.04 6.85 7.45 7.65 7.94 7.1 6.89 6.92 6.99 7.98
Total hardness (as 
calcium carbonate)
NMT	600	mg/l 47 48 52 56 58 54 62 65 64 58
Chloride (as chlorine) NMT	1000	mg/l 438 485 468 446 428 439 478 469 476 488
Dissolved solids NMT	2000	mg/l 576 568 535 564 546 588 539 574 589 569
Table 7: Sampling point: SP07 (after softner)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 6.5-8.5 6.54 6.24 6.56 6.48 6.48 6.44 6.12 7.14 6.34 6.14
Total hardness (as 
calcium carbonate)
NMT	600	mg/l Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Chloride (as chlorine) NMT	1000	mg/l Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Dissolved solids NMT	2000	mg/l 287 297 248 276 298 323 302 278 267 283
Table 8: Sampling point: SP102 (after ultra‑filtration)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.99 6.87 6.88 6.91 6.97 6.88 6.89 6.98 7.01 7.04
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 3.2 3.0 3.4 2.9 2.7 3.2 3.1 2.9 2.8 3.1
Bacterial 
Endotoxins
NMT	0.2EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Table 9: Sampling point: SP201 (after 10 μ filter)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless liquid
A clear, colourless and tasteless liquid
pH 5.0	to	7.0 5.32 5.41 5.42 5.31 5.48 4.85 5.39 5.94 4.91 5.13
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.3 2.8 2.5 2.1 2.9 2.7 3.2 3.1 2.6 2.4
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
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Table 10: Sampling point: SP204 (After reverse osmosis‑1)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.1 2.3 2.8 2.5 2.1 2.9 2.7 2.9 2.6 2.4
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Table 11: Sampling point: SP302 (After pH Correction)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.45 6.35 6.45 6.94 6.45 6.37 6.15 6.48 6.24 6.27
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.4 2.6 2.1 2.6 2.4 2.9 2.7 2.4 2.6 2.1
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Table 12: Sampling point: SP306 (After reverse osmosis‑2)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.23 6.41 6.84 6.48 6.29 6.46 6.29 6.58 6.49 6.44
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.1 2.3 2.8 2.5 2.1 2.3 2.8 2.5 2.1 2.3
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
from the water; the results are shown in Table	6	(Sampling	point:	SP04).
•	 Water	softeners	of	an	alternated	sodium	resin	which	can	remove	hard	





•	 RO	 is	 the	 finest	 filtration	open,	RO	removes	90-99%	of	particles,	
bacteria, pyrogens, colloids, dissolved organic, and inorganic 
substances >200-300 molecular weight range or larger than the 
membrane’s	pore	size	of	150-200	angstroms;	the	results	are	shown	






and salts, and some dissolved organic matter, from the water stream 
crossing ion exchange resins, the results are shown in Table 13 
(Sampling	point:	SP309).
•	 Ultraviolet	light	(λ=254	nm)	is	used	in	the	final	step	in	the	treatment	
for the purpose of avoiding the growth of microorganisms, and 




•	 TOC	 test	 is	 executed	 for	water	 samples,	 results	 are	within	 the	
acceptance	limits	(<500	ppb).
•	 Chemical	 and	microbial	 analysis,	we	 found	 that	 the	 results	 are	
complies with in the limits.
415
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Water treatment systems need be operated within regulatory guidelines 
as with pharmaceutical production facilities. To validate these systems, 
there should be documented evidence that the system is operating 
constantly and allowing to the desired specifications. Validation is 
a tool for total quality management and it is necessary for process 
optimisation, efficacy, safety, and assurance of quality. Such validation 
protocols fulfill regulatory requirements and deliver good business 
Table 13: Sampling point: SP309 (After electron de‑ionization system)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.44 6.12 7.14 6.34 6.14 6.54 6.24 6.56 6.48 6.48
Heavy	metals NMT	0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.9 2.8 3.1 3.2 3.0 3.4 2.9 2.7 3.2 3.1
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Table 14: Sampling point: SP311 (After UV)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.25 6.36 6.45 6.14 6.85 6.45 6.35 6.56 6.84 6.38
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.8 3.1 2.9 3.4 3.5 2.9 2.3 3.9 3.4 2.8
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Table 15: Sampling point: SP401 (PW Storage tank)
Test Specification Date of sampling and results
25/8/16 26/8/16 29/8/16 30/8/16 31/8/16 01/9/16 06/9/16 07/9/16 08/9/16 10/9/16
Description A clear, colourless 
and tasteless 
liquid
A clear, colourless and tasteless liquid
pH 5.0-7.0 6.12 6.24 6.07 6.45 5.98 6.41 6.22 6.31 6.11 6.04
Heavy	metals NMT	0.1	ppm <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Nitrates NMT	0.2	ppm <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
Aluminium NMT	10	ppb <10 <10 <10 <10 <10 <10 <10 <10 <10 <10
Conductivity NMT	5.1	µS/cm 2.4 2.6 2.1 2.3 2.8 2.5 2.6 2.4 2.9 2.7
Bacterial 
endotoxins
NMT	0.2	EU/mg <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2 <0.2
sense. Successful execution of validation is ensured by various testing 
phases. A three-phase testing approach is suggested over an extended 
period to prove robustness and reliability of the system for producing 
water of specified quality with a high degree of assurance.
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